News summaryReutersOct 28, 2026, 12:00 PM
Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals
REGNpharmaceuticals
Canaccord Genuity has revised its price target for Regeneron Pharmaceuticals, increasing it from $875 to $922.
Loading...
Canaccord Genuity has revised its price target for Regeneron Pharmaceuticals, increasing it from $875 to $922.